Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/66506
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSharma, Anshul-
dc.contributor.authorVerma, Shweta-
dc.date.accessioned2025-09-30T04:21:39Z-
dc.date.available2025-09-30T04:21:39Z-
dc.date.issued2025-09-
dc.identifier.issn2583-1321 (Online);0019-5103 (Print)-
dc.identifier.urihttp://nopr.niscpr.res.in/handle/123456789/66506-
dc.description907-917en_US
dc.description.abstractThe present research article describes the synthesis, characterization and pharmacological estimation of pyrazole derivatives with antianxiety and skeletal muscle relaxant properties, which are used for treatment of anxiety and depression in humans as well as animals. A series of pyrazole derivatives (AS1-AS7) have been synthesized, out of which, compounds AS1 and AS7 have been found to have high skeletal muscle relaxant and anti-anxiety properties.en_US
dc.language.isoenen_US
dc.publisherNIScPR-CSIR, Indiaen_US
dc.sourceIJC Vol.64(09) [September 2025]en_US
dc.subjectPyrazoleen_US
dc.subjectBenzaldehydesen_US
dc.subjectAntianxiety activityen_US
dc.subjectSkeleton Muscle Relaxanten_US
dc.subjectAntianxietyen_US
dc.titleSynthesis, characterization and pharmacological evaluation of pyrazole derivatives as potent CNS agentsen_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.56042/ijc.v64i9.19318en_US
Appears in Collections:IJC Vol.64(09) [September 2025]

Files in This Item:
File Description SizeFormat 
IJC 64(9) 907-917.pdf8.35 MBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.